Xencor Inc’s recently made public that its Officer Eckert Celia acquired Company’s shares for reported $78047.0 on Mar 10 ’25. In the deal valued at $13.60 per share,5,740 shares were bought.
Then, Valente Nancy bought 2,565 shares, generating $34,877 in total proceeds.
Before that, Desjarlais John R bought 9,697 shares. Xencor Inc shares valued at $131,851 were divested by the Officer at a price of $13.60 per share.
Wells Fargo initiated its Xencor Inc [XNCR] rating to an Overweight in a research note published on December 12, 2024; the price target was $37. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who increased its forecast for the stock in early December from “a Neutral” to “an Overweight”. BTIG Research also remained covering XNCR and reiterated its “Buy” recommendation on April 16, 2024. Piper Sandler revised its rating on February 28, 2024. It rated XNCR as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of XNCR
On Monday, Xencor Inc [NASDAQ:XNCR] saw its stock fall -1.73% to $13.63. Over the last five days, the stock has lost -5.74%. Xencor Inc shares have fallen nearly -40.69% since the year began. Nevertheless, the stocks have fallen -42.80% over the past one year. While a 52-week high of $27.24 was reached on 01/06/25, a 52-week low of $13.42 was recorded on 03/10/25. SMA at 50 days reached $18.50, while 200 days put it at $20.32.
Levels Of Support And Resistance For XNCR Stock
The 24-hour chart illustrates a support level at 13.42, which if violated will result in even more drops to 13.21. On the upside, there is a resistance level at 13.84. A further resistance level may holdings at 14.05. The Relative Strength Index (RSI) on the 14-day chart is 22.78, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.92, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.57%. Stochastics %K at 11.00% indicates the stock is a buying.
The most recent change occurred on May 19, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $42 price target.
